News | July 26, 2025
Laurus Labs consolidated Q1 FY2026 PAT at Rs. 163.02 Cr
Laurus Labs has reported total income of Rs. 1,580 crores during the period ended June 30, 2025
Laurus Labs has reported total income of Rs. 1,580 crores during the period ended June 30, 2025
Vimta Labs has reported total income of Rs. 99.31 crores during the period ended June 30, 2025
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
Vimta Labs has reported total income of Rs. 96.08 crores during the period ended March 31, 2025
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
The company has reported total income of Rs. 628.4 crores during the period ended March 31, 2025
The 27 greenfield labs across the country ensure timely and accurate reporting
The company delivered revenues of Rs. 5,554 crore, representing 10% growth in FY25
Aarti Pharmalabs becomes 6th Indian Pharma/CDMO to earn SBTi approval for all 3 Scopes since 2022 demerger
Subscribe To Our Newsletter & Stay Updated
